Use of antihypertensive medications not associated with risk of contralateral breast cancer among women diagnosed with estrogen-receptor positive invasive breast cancer

Documenti analoghi

• Relationship Between Potentially Modifiable Lifestyle Factors and Risk of Second Primary Contralateral Breast Cancer Among Women Diagnosed With Estrogen Receptor–Positive Invasive Breast Cancer
  di: Li, Christopher I., et al.
  Pubblicazione: (2009)
• Bisphosphonate Use After Estrogen Receptor–Positive Breast Cancer and Risk of Contralateral Breast Cancer
  di: Monsees, Genevieve M., et al.
  Pubblicazione: (2011)
• Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancer
  di: Saltzman, Babette Siebold, et al.
  Pubblicazione: (2012)
• Active smoking and risk of estrogen receptor positive and triple-negative breast cancer among women 20–44 years of age
  di: Kawai, Masaaki, et al.
  Pubblicazione: (2014)
• Height, BMI, BMI change and the risk of estrogen receptor positive, HER2 positive and triple-negative breast cancer among women ages 20 to 44 years
  di: Kawai, Masaaki, et al.
  Pubblicazione: (2014)